CA
NZ
UK
AU
IND
US
…
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 160.24M | 280.23M | 210.82M | 170.41M | 158.99M |
| Minority interest | -0.91M | 1.09M | 1.58M | 1.07M | 0.78M |
| Net income | 118.61M | 209.07M | 183.61M | 126.83M | 119.35M |
| Selling general administrative | 754.06M | 711.24M | 668.30M | 607.93M | 501.31M |
| Gross profit | 962.77M | 980.76M | 886.15M | 805.30M | 669.72M |
| Reconciled depreciation | 70.96M | 71.27M | 67.94M | 54.33M | 13.26M |
| Ebit | 180.77M | 251.91M | 219.27M | 177.47M | 166.36M |
| Ebitda | 256.44M | 329.92M | 293.95M | 240.73M | 179.62M |
| Depreciation and amortization | 75.67M | 78.01M | 74.68M | 63.26M | 13.26M |
| Non operating income net other | 1.70M | 37.84M | 2.59M | 7.45M | 11.21M |
| Operating income | 180.77M | 251.91M | 219.27M | 177.47M | 155.15M |
| Other operating expenses | 2039.42M | 1962.20M | 1848.10M | 1776.69M | 1507.43M |
| Interest expense | 22.23M | 9.53M | 11.04M | 14.52M | 7.37M |
| Tax provision | 42.55M | 70.06M | 25.64M | 42.50M | 38.86M |
| Interest income | 0.18M | 0.05M | 0.29M | 0.08M | 0.28M |
| Net interest income | -22.05M | -9.48M | -10.75M | -14.44M | -7.09M |
| Non recurring | 3.01M | - | 4.15M | 1.47M | - |
| Income tax expense | 42.55M | 70.06M | 25.64M | 42.50M | 38.86M |
| Total revenue | 2223.20M | 2214.11M | 2071.52M | 1955.63M | 1662.58M |
| Total operating expenses | 778.99M | 728.84M | 662.73M | 626.35M | 514.57M |
| Cost of revenue | 1260.42M | 1233.36M | 1185.37M | 1150.34M | 992.86M |
| Total other income expense net | -20.53M | 28.32M | -8.45M | -7.06M | 10.93M |
| Net income from continuing ops | 117.70M | 210.17M | 185.18M | 127.91M | 120.13M |
| Net income applicable to common shares | 118.61M | 209.07M | 183.61M | 126.83M | 119.30M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 2060.17M | 1976.24M | 1856.97M | 1567.20M | 1262.74M |
| Intangible assets | 102.67M | 101.17M | 111.19M | 74.18M | 64.75M |
| Other current assets | 22.90M | 26.41M | 25.60M | 13.27M | 8.22M |
| Total liab | 940.39M | 869.67M | 880.64M | 756.46M | 621.23M |
| Total stockholder equity | 1066.51M | 1051.57M | 931.35M | 809.22M | 640.45M |
| Deferred long term liab | - | 20.41M | - | - | - |
| Other current liab | 382.88M | -20148.22M | -3.36M | 313.12M | -3.09M |
| Common stock | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M |
| Capital stock | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M |
| Retained earnings | 747.92M | 757.67M | 639.06M | 429.99M | 246.38M |
| Other liab | - | 25.22M | 4.98M | 33.62M | 5.91M |
| Good will | 1244.68M | 1287.40M | 1196.09M | 932.68M | 658.50M |
| Other assets | - | 39.34M | 73.31M | 174.63M | 0.01M |
| Cash | 145.86M | 40.54M | 42.69M | 81.81M | 30.29M |
| Total current liabilities | 473.72M | 355.53M | 374.28M | 456.34M | 326.94M |
| Current deferred revenue | - | 20411.00M | 295.20M | 60.00M | 261.08M |
| Net debt | 341.35M | 497.40M | 502.92M | 225.23M | 295.79M |
| Short term debt | 62.60M | 49.02M | 44.23M | 40.54M | 37.70M |
| Short long term debt | 36.31M | 15.50M | 12.99M | 10.50M | 8.23M |
| Short long term debt total | 487.21M | 537.94M | 545.61M | 307.04M | 326.08M |
| Other stockholder equity | 318.55M | 293.86M | 292.25M | 379.19M | 394.01M |
| Property plant equipment | - | 16.03M | 119.69M | 23.72M | 28.11M |
| Total current assets | 496.94M | 388.96M | 356.68M | 361.98M | 350.55M |
| Long term investments | 66.10M | 60.50M | 53.10M | 14.20M | 35.70M |
| Net tangible assets | - | -336.99M | -375.93M | -197.64M | -82.80M |
| Net receivables | 328.17M | 296.79M | 274.96M | 255.15M | 237.60M |
| Long term debt | 361.86M | 419.42M | 432.07M | 204.51M | 232.26M |
| Inventory | - | 25.22M | 13.43M | 11.77M | 74.44M |
| Accounts payable | 28.24M | 43.73M | 38.22M | 42.67M | 31.26M |
| Noncontrolling interest in consolidated entity | - | 55.00M | 44.97M | 1.52M | 1.06M |
| Accumulated other comprehensive income | 0.00M | - | - | - | 0.01M |
| Common stock total equity | - | 0.04M | 0.04M | 0.04M | 0.04M |
| Retained earnings total equity | - | 757.67M | 639.06M | 429.99M | 246.38M |
| Treasury stock | - | -461.20M | -435.87M | -319.09M | -251.24M |
| Non currrent assets other | -35.24M | -20391.66M | 19.92M | 19.00M | 18.91M |
| Non current assets total | 1563.23M | 1587.28M | 1500.28M | 1205.21M | 912.19M |
| Capital lease obligations | 89.04M | 103.03M | 100.54M | 92.03M | 87.30M |
| Long term debt total | - | 419.42M | 432.07M | 204.51M | 232.26M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -15.64M | -5.20M | 17.00M | -0.21M | -7.14M |
| Change to liabilities | -43.31M | -4.35M | 69.50M | 30.44M | 19.13M |
| Total cashflows from investing activities | -94.49M | -281.61M | -287.11M | -352.95M | -22.19M |
| Net borrowings | -13.30M | 230.17M | -29.25M | 56.03M | -86.38M |
| Total cash from financing activities | -30.43M | 55.13M | -14.98M | 227.21M | -267.42M |
| Change to operating activities | -95.71M | -108.64M | 22.17M | 4.12M | 27.59M |
| Net income | 117.70M | 210.17M | 185.18M | 127.91M | 120.13M |
| Change in cash | 8.36M | -37.59M | -13.13M | 76.26M | -66.13M |
| Begin period cash flow | 45.77M | 83.36M | 96.49M | 20.23M | 86.36M |
| End period cash flow | 54.13M | 45.77M | 83.36M | 96.49M | 20.23M |
| Total cash from operating activities | 133.28M | 188.89M | 288.95M | 202.00M | 223.48M |
| Depreciation | 70.96M | 71.27M | 67.94M | 54.33M | 13.26M |
| Other cashflows from investing activities | -72.68M | 0.14M | -298.78M | -344.85M | -8.49M |
| Dividends paid | 1.56M | -3968.00M | -3562.00M | -3187.00M | 143.95M |
| Change to inventory | - | - | -2.04M | 7.12M | 22.20M |
| Change to account receivables | -14.23M | -18.03M | 2.11M | -24.15M | 12.22M |
| Sale purchase of stock | -25.33M | -116.78M | -54.49M | -9.56M | -187.97M |
| Other cashflows from financing activities | -1774.60M | 723.60M | 742.72M | 436.76M | 192.57M |
| Change to netincome | 48.67M | 38.66M | 5.77M | 50.24M | 46.31M |
| Capital expenditures | 7.21M | 6.72M | 5.33M | 7.89M | 6.56M |
| Change receivables | -14.23M | -18.03M | 2.11M | -24.15M | 12.22M |
| Cash flows other operating | -1.48M | -12.56M | -3.28M | -1.74M | 11.63M |
| Cash and cash equivalents changes | 8.36M | -37.59M | -13.13M | 76.26M | -66.13M |
| Change in working capital | -105.04M | -131.02M | 26.22M | -31.36M | 42.98M |
| Stock based compensation | 16.56M | 23.81M | 26.73M | 25.04M | 17.89M |
| Other non cash items | 9.73M | -29.91M | 9.43M | 12.61M | 8.95M |
| Free cash flow | 126.07M | 182.17M | 283.62M | 194.11M | 216.93M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare, Inc. |
-4.89 1.02% |
473.19 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
2.68 0.99% |
273.25 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.31 2.36% |
13.35 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.09 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
3854 American Way, Baton Rouge, LA, United States, 70816
225 292 2031
18700
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul Berthold Kusserow | Chairman & CEO | 1961 |
| Mr. Scott G. Ginn | Exec. VP, CFO & Acting COO | 1969 |
| Mr. Pete Hartley | CTO & Sr. VP of Bus. Operations Systems | NA |
| Mr. Michael P. North | Chief Information Officer | 1965 |
| Ms. Jennifer Guckert Griffin | Sr. VP, Deputy Gen. Counsel, Corp. Sec. & Interim Chief Legal Officer | NA |
| Ms. Denise Bohnert | Chief Compliance Officer | 1978 |
| Kendra Kimmons | VP of Marketing & Communications & Media Relations | NA |
| Mr. Adam Holton | Chief People Officer | NA |
| Mr. John Nugent | Chief Acquisitions Officer | NA |
| Ms. Janet Britt | Sr. VP of Billing & Collections | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...